Sanofi Pasteur
174, av. de France
Paris
75013
France
Tel: 33-1-53-77-4076
Fax: 33-1-53-77-4174
Website: http://en.sanofi-aventis.com/
189 articles about Sanofi Pasteur
-
Sanofi Pasteur To Fill US Vaccine Supply Gap Caused By Merck & Co., Inc.
6/26/2009
-
Delphi Genetics Grants Licence to Sanofi Pasteur for Antibiotic-Free Manufacturing of Biological Products
6/15/2009
-
Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine
5/27/2009
-
Sanofi Pasteur Receives Order from U.S. Government to Produce New Influenza A(H1N1) Vaccine
5/26/2009
-
PAHEF Announces $1.2+ Million Grant From Sanofi Pasteur
3/13/2009
-
Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
2/18/2009
-
Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
2/17/2009
-
Sanofi Pasteur Accesses ProBioGen AG's AGE1.CR® Cell Lines for Various Pox-vectored Vaccine Products Under Development
2/3/2009
-
Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants
11/12/2008
-
Sanofi Pasteur High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older
10/27/2008
-
Sanofi Pasteur Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
9/18/2008
-
FDA Approves 2008-2009 Season's Flu Vaccines: CSL Limited, Afluria. GlaxoSmithKline Biologicals, Fluarix. ID Biomedical Corporation of Quebec, FluLaval. MedImmune Vaccines, FluMist. Novartis Vaccines & Diagnostics, Inc., Fluvirin. Sanofi Pasteur, Fluzone.
8/6/2008
-
Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season
8/1/2008
-
Federal Advisory Committee Votes to Include Newly Licensed Sanofi Pasteur Pentacel(R) Vaccine in Vaccines for Children Program
6/26/2008
-
FDA Licenses Sanofi Pasteur's New Pediatric Combination Vaccine, Pentacel(R)
6/23/2008
-
Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to World Health Organization Over 3 Years for its Influenza Vaccine Global Stockpile
6/16/2008
-
Flu Vaccine Makers To Set New Doses Record For Next Season, CSL Biotherapies, Sanofi Pasteur, Novartis Vaccines and Diagnostics, GlaxoSmithKline, and MedImmune Vaccines
5/13/2008
-
U.S. Government Accepts $192 Million of Sanofi Pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
4/28/2008
-
Crucell N.V. Announces Start of Phase II Clinical Study Rabies Monoclonal Antibody Combination in US; First Milestone Achieved in Collaboration Agreement with Sanofi Pasteur
3/31/2008
-
Acambis PLC Extends Sanofi Pasteur Licensing Agreement for ChimeriVax-JE Vaccine
3/20/2008